Isotretinoin SCP contains the active ingredient isotretinoin
Consumer Medicine Information What is in this leaflet 6. you have very high fat levels Ask your doctor if you have any (cholesterol, triglycerides) in questions about why Isotretinoin your blood SCP has been prescribed for you. 7. you have hypervitaminosis A
It does not take the place of talking to
8. the packaging is torn or shows signs of tampering 9. the expiry date (EXP) printed on the pack has passed.
against the benefits they expect it will
Do not take Isotretinoin SCP if: If you have any concerns about 1. you are pregnant, or for at least taking this medicine, ask your doctor one month before you plan to If you are not sure if you should or pharmacist. fall pregnant start taking Isotretinoin SCP, contact your doctor. Keep this leaflet with the medicine. Do not give Isotretinoin SCP to children. 2. you are breastfeeding Tell your doctor if: 1. you have any allergies to any other medicines, foods, preservatives or dyes 3. you have had an allergic reaction to Isotretinoin SCP, vitamin A, other retinoids or any 2. you have or have had any other other ingredients of Isotretinoin health problems or issues SCP (listed at the end of this including: leaflet)
diabetes, or a history of diabetes in
4. you are taking tetracycline antibiotics (such as Akamin®, Vibramycin®, Doxycycline hydrochloride, Doryx®, Frakas®, Minomycin®) Your doctor, however, may have prescribed Isotretinoin SCP for 5. you have severe liver disease another purpose.
C: Products/Isotret/CMI 29nov10 SCP 29/11/10 Page 1 of 4
3. you drink large amounts of alcohol. If you have not told your doctor If it is almost time for your next about any of the above, tell them dose, skip the dose you missed and before you start taking Isotretinoin take the next dose when you are meant to. Tell your doctor or pharmacist if you are taking any other medicines, including any that you get without a prescription, from a pharmacy, supermarket or health food shop. Immediately telephone your doctor, or Poisons Information Centre (telephone 13 11 26) for advice, or go to Accident and Emergency at your nearest hospital, if you think you or anyone else may have taken too much Isotretinoin SCP. Do this even if there are no signs of discomfort or poisoning. Female patients should wait until the 2nd or 3rd day of the next normal
the "mini-pill", a progestogen-only
menstrual period before starting Isotretinoin SCP treatment. Keep telephone numbers for these Continue taking Isotretinoin SCP for places handy. as long as your doctor prescribes.
will probably get a little worse before it
If you become pregnant while taking Ask your doctor or pharmacist if Isotretinoin SCP, stop taking it and you are not sure about this list of tell your doctor immediately. medicines.
At the end of this time your acne should have cleared up significantly.
Follow all directions given to you by your doctor or pharmacist carefully. Take Isotretinoin SCP exactly as Tell all doctors, dentists and your doctor has prescribed. pharmacists who are treating you that you are taking Isotretinoin SCP. Do not try to make up for missed doses by taking an extra dose.
C: Products/Isotret/CMI 29nov10 SCP 29/11/10 Page 2 of 4
Tell your doctor if, for any reason, you have not taken your medicine exactly as prescribed.
be dangerous if your vision is affected.
Wearing contact lenses during treatment with Isotretinoin SCP may cause discomfort. Tell your doctor if you feel Isotretinoin SCP capsules are not helping your condition. Be sure to keep all of your appointments with your doctor so that your progress can be checked. Avoid excessive sun exposure and solariums and apply a sunscreen while taking Isotretinoin SCP.
tenderness or stiffness in your bones, joints or muscles
If you are intending to do a lot of heavy lifting or exercise, tell your Avoid waxing and dermabrasion while taking Isotretinoin SCP and for 5 to 6 months after stopping Isotretinoin SCP treatment. Do not stop taking Isotretinoin SCP or change the dose without first checking with your doctor. Avoid using facial peels, electrolysis Do not let yourself run out of and some hair treatments. medicine over the weekend or on Tell your doctor immediately if you holidays. experience any of the following: Do not give Isotretinoin SCP to anyone else even if their symptoms seem similar to yours. Do not use Isotretinoin SCP to treat other complaints unless your doctor Do not donate blood during treatment with Isotretinoin SCP or for at least 1 month after stopping treatment. Be careful driving or operating machinery until you know how Isotretinoin SCP affects you. Ask your doctor or pharmacist to answer any questions you may have. Tell your doctor if you notice any of the following and they worry you:
C: Products/Isotret/CMI 29nov10 SCP 29/11/10 Page 3 of 4
Keep Isotretinoin SCP where young children cannot reach it. Protect Isotretinoin SCP from light. If your doctor tells you to stop taking Isotretinoin SCP, or the capsules have passed their expiry date, ask your pharmacist what to do with any capsules that are left over. Date of Information: Tell your doctor if you notice anything else that is making you feel unwell, even if it is not on this list. Ask your doctor or pharmacist if you don't understand anything in this list. Active ingredient - isotretinoin Keep your capsules in the blister pack until it is time to take them. Inactive ingredients - Keep the blister pack in a cool dry place where the temperature stays below 25oC. Do not store Isotretinoin SCP, or any other medicine, in a bathroom or near a sink. Do not leave it in the car or on window sills.
C: Products/Isotret/CMI 29nov10 SCP 29/11/10 Page 4 of 4
Treatment of Acute and Chronic Rhinosinusitis in the United States, 1999-2002 Hadley J. Sharp, BS; David Denman, MD; Susan Puumala, MS; Donald A. Leopold, MD Objective: To generalize the prescribing trends of a sta- nasal decongestants; corticosteroids; and antitussive, ex-tistically defined sample of patient visits because of acutepectorant, and mucolytic agents, respectively. In addi-
Correspondence Letters to the Editor must not exceed 400 words in length and may be subject to editing or abridgment. Letters must be limited to threeauthors and five references. They should not have tables or figures and should relate solely to an article published in Circulation withinthe preceding 12 weeks. Only some letters will be published. Authors of those selected for publication wil